Following The Court of Justice of the European Union ruling that certain parthenotes can be patentable (if such cells develop in a way that mean it would not be possible for them to become a fully-formed human being), Penny Gilbert discuss the law and science behind the judgment. 

The judgment is likely to have significant consequences for stem cell therapy research in Europe: read the full article here, as originally published by LexisNexis.